Increasing Prevalence of HSV-2 Points to Need for More Effective Prevention Strategies

Herpes

Volumn 9, Issue 1, 2002, Pages 3-

  Corey, Lawrence ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; HERPES SIMPLEX VACCINE; NONOXINOL 9; VACCINE;

AFRICA; BLOOD DONOR; CARIBBEAN ISLANDS; CONDOM; EDITORIAL; HEALTH PROMOTION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HIGH RISK POPULATION; HUMAN; INFECTION PREVENTION; INFECTION RATE; MATHEMATICAL MODEL; OUTCOMES RESEARCH; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SEROPREVALENCE; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SOUTH AMERICA; TECHNIQUE; UNITED STATES; VIRUS TRANSMISSION; DISEASE TRANSMISSION; GENITAL HERPES; ISOLATION AND PURIFICATION; NOTE; VIROLOGY;

HUMAN HERPESVIRUS 2; SIMPLEXVIRUS;

HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HUMANS; PREVALENCE;

EID: 0036547080     PISSN: 09697667     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (3)

1. Armstrong GL, Schillinger J, Markowitz L, Nahmias AJ, Johnson RE, McQuillan GM et al. Incidence of herpes simplex virus type 2 infection in the United States. Am J Epidemiol 2001;153:912-920.
2. Vontver LA, Reeves WC, Rattray M, Corey L, Remington MR, Tolentino E et al. Clinical course and diagnosis of genital herpes simplex virus infection and evaluation of topical surfactant therapy. Am J Obstet Gynecol 1979;133:548-554.
3. Roddy Re, Zekeng L, Ryan KA, Tamoufe U, Weir SS, Wong EL. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases. N Engl J Med 1998;339:504-510.